Naair will report to CEO Shreehas Tambe and joins the Executive Leadership Team; Seema Ahuja to transition to a new role in ...

Shares of Biocon experienced a decline of 2.01% to Rs 386.70 in Tuesday's session, with the stock figuring among the top ...

The shares of biopharmaceutical firm Biocon fell as much as 2.04 per cent in Tuesday's trading session, figuring among top ...

Nepexto will be promoted by Generic Health, BBL's local partner and a leading provider of high-quality generic prescription, ...

Biocon Biologics on Wednesday announced the appointment of Deepali Naair as Global Head Brand & Corporate Communications, ...

Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it ...

With over three decades of experience across India, ASEAN, and Australia, Deepali Naair brings deep expertise in brand ...

Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Biocon Biologics appoints Deepali Naair as Global Head of Brand & Corporate Communications. She brings 30+ years experience ...

Etanercept is a TNF (tumor necrosis factor) inhibitor used to treat several autoimmune conditions, including rheumatoid ...